Replies to post #156546 on NorthWest Biotherapeutics Inc (NWBO)

[jondoeuk]

They are targeting a single lesion with low-dose radiation on days 1, 2 and then injecting SD-101 (a TLR9 agonist made by Dynavax) into the same lesion on days 2, 9, 16, 23, and 30. BMS-986178 (anti-OX40 mAb) is given via IV infusion on days 3, 30, 58, 86, 114, and 142.